[]

Find Clinical Drug Pipeline Developments & Deals for Bexaroten

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          ReXceptor

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          ReXceptor

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          February 13, 2014

                          Lead Product(s) : Bexarotene

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Dartmouth-Hitchcock Medical Center

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Dartmouth-Hitchcock Medical Center

                          Country arrow
                          Peptide Process CMC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Targretin

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          May 05, 2010

                          Lead Product(s) : Bexarotene

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase I

                          Sponsor : Genentech | Ligand Pharmaceuticals

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank